1. Home
  2. FBIOP vs DAY Comparison

FBIOP vs DAY Comparison

Compare FBIOP & DAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIOP
  • DAY
  • Stock Information
  • Founded
  • FBIOP N/A
  • DAY 1992
  • Country
  • FBIOP United States
  • DAY United States
  • Employees
  • FBIOP 101
  • DAY N/A
  • Industry
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • DAY
  • Sector
  • FBIOP Health Care
  • DAY
  • Exchange
  • FBIOP Nasdaq
  • DAY NYSE
  • Market Cap
  • FBIOP N/A
  • DAY N/A
  • IPO Year
  • FBIOP N/A
  • DAY 2018
  • Fundamental
  • Price
  • FBIOP $6.74
  • DAY $57.27
  • Analyst Decision
  • FBIOP
  • DAY Buy
  • Analyst Count
  • FBIOP 0
  • DAY 13
  • Target Price
  • FBIOP N/A
  • DAY $75.62
  • AVG Volume (30 Days)
  • FBIOP N/A
  • DAY 1.8M
  • Earning Date
  • FBIOP N/A
  • DAY 05-07-2025
  • Dividend Yield
  • FBIOP N/A
  • DAY N/A
  • EPS Growth
  • FBIOP N/A
  • DAY N/A
  • EPS
  • FBIOP N/A
  • DAY 0.11
  • Revenue
  • FBIOP N/A
  • DAY $1,760,000,000.00
  • Revenue This Year
  • FBIOP N/A
  • DAY $10.91
  • Revenue Next Year
  • FBIOP N/A
  • DAY $12.24
  • P/E Ratio
  • FBIOP N/A
  • DAY $520.64
  • Revenue Growth
  • FBIOP N/A
  • DAY 16.27
  • 52 Week Low
  • FBIOP N/A
  • DAY $47.08
  • 52 Week High
  • FBIOP N/A
  • DAY $82.69
  • Technical
  • Relative Strength Index (RSI)
  • FBIOP 67.87
  • DAY 53.00
  • Support Level
  • FBIOP $6.00
  • DAY $51.98
  • Resistance Level
  • FBIOP $6.80
  • DAY $56.97
  • Average True Range (ATR)
  • FBIOP 0.42
  • DAY 2.89
  • MACD
  • FBIOP 0.16
  • DAY 0.39
  • Stochastic Oscillator
  • FBIOP 96.19
  • DAY 98.20

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: